Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome P-450 CYP1A1 | 10 | 2017 | 52 | 2.820 |
Why?
|
| Ceramides | 9 | 2023 | 43 | 2.800 |
Why?
|
| Cytochrome P-450 CYP1A2 | 7 | 2017 | 28 | 2.140 |
Why?
|
| Flavones | 4 | 2023 | 10 | 2.050 |
Why?
|
| Enzyme Inhibitors | 12 | 2014 | 457 | 1.860 |
Why?
|
| Cytochrome P-450 Enzyme System | 9 | 2023 | 99 | 1.550 |
Why?
|
| Coumarins | 4 | 2019 | 43 | 1.460 |
Why?
|
| Antineoplastic Agents | 6 | 2018 | 979 | 1.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 8 | 2016 | 51 | 0.940 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 1679 | 0.930 |
Why?
|
| Nicotine | 1 | 2023 | 290 | 0.670 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2019 | 3 | 0.620 |
Why?
|
| Xenobiotics | 1 | 2019 | 14 | 0.610 |
Why?
|
| Tumor Burden | 1 | 2018 | 84 | 0.580 |
Why?
|
| Anthraquinones | 1 | 2017 | 9 | 0.520 |
Why?
|
| Structure-Activity Relationship | 8 | 2015 | 491 | 0.500 |
Why?
|
| Cell Line, Tumor | 8 | 2024 | 2598 | 0.440 |
Why?
|
| Alkynes | 2 | 2012 | 50 | 0.440 |
Why?
|
| Ethers | 2 | 2012 | 20 | 0.440 |
Why?
|
| Ligands | 4 | 2017 | 387 | 0.440 |
Why?
|
| Models, Molecular | 7 | 2019 | 875 | 0.420 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2014 | 290 | 0.420 |
Why?
|
| Drug Design | 3 | 2015 | 183 | 0.410 |
Why?
|
| Humans | 31 | 2024 | 42163 | 0.390 |
Why?
|
| Dimethyl Sulfoxide | 2 | 2023 | 15 | 0.360 |
Why?
|
| Kinetics | 6 | 2015 | 698 | 0.350 |
Why?
|
| Catalytic Domain | 5 | 2014 | 118 | 0.340 |
Why?
|
| Quantitative Structure-Activity Relationship | 3 | 2019 | 110 | 0.310 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2017 | 98 | 0.290 |
Why?
|
| Apoptosis | 6 | 2023 | 1541 | 0.280 |
Why?
|
| Phenanthrenes | 3 | 2016 | 16 | 0.240 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2018 | 31 | 0.240 |
Why?
|
| Carcinogens | 2 | 2023 | 126 | 0.220 |
Why?
|
| Mice | 5 | 2024 | 6490 | 0.220 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2024 | 44 | 0.220 |
Why?
|
| Fluorometry | 2 | 2014 | 17 | 0.210 |
Why?
|
| Animals | 11 | 2024 | 16695 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 339 | 0.200 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 479 | 0.190 |
Why?
|
| Cell Proliferation | 2 | 2023 | 1420 | 0.180 |
Why?
|
| Flavonoids | 3 | 2013 | 94 | 0.180 |
Why?
|
| Cell Survival | 4 | 2020 | 934 | 0.170 |
Why?
|
| Lymphoma, Primary Effusion | 1 | 2020 | 1 | 0.170 |
Why?
|
| Sphingolipids | 1 | 2020 | 14 | 0.170 |
Why?
|
| Sarcoma, Kaposi | 1 | 2020 | 24 | 0.170 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2015 | 49 | 0.170 |
Why?
|
| Protein Binding | 5 | 2017 | 1076 | 0.170 |
Why?
|
| Government Programs | 1 | 2020 | 29 | 0.170 |
Why?
|
| Herpesvirus 8, Human | 1 | 2020 | 29 | 0.170 |
Why?
|
| Splenic Neoplasms | 1 | 2018 | 2 | 0.150 |
Why?
|
| Cultural Diversity | 1 | 2020 | 187 | 0.150 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 34 | 0.150 |
Why?
|
| Naphthalenes | 2 | 2016 | 38 | 0.140 |
Why?
|
| Biphenyl Compounds | 2 | 2016 | 52 | 0.140 |
Why?
|
| Oxidation-Reduction | 3 | 2016 | 448 | 0.140 |
Why?
|
| Adamantane | 1 | 2018 | 9 | 0.140 |
Why?
|
| Kidney Neoplasms | 1 | 2018 | 77 | 0.140 |
Why?
|
| Pyrenes | 2 | 2015 | 26 | 0.140 |
Why?
|
| Binding Sites | 3 | 2014 | 670 | 0.140 |
Why?
|
| NADP | 2 | 2014 | 37 | 0.130 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 233 | 0.130 |
Why?
|
| Mice, Nude | 1 | 2018 | 403 | 0.130 |
Why?
|
| Female | 6 | 2023 | 24018 | 0.130 |
Why?
|
| Glucosyltransferases | 2 | 2014 | 7 | 0.130 |
Why?
|
| Enzyme Assays | 1 | 2017 | 13 | 0.130 |
Why?
|
| Pyridines | 1 | 2018 | 134 | 0.130 |
Why?
|
| Phenylalanine | 1 | 2017 | 25 | 0.130 |
Why?
|
| Substrate Specificity | 1 | 2017 | 217 | 0.130 |
Why?
|
| Universities | 1 | 2020 | 539 | 0.130 |
Why?
|
| Models, Chemical | 2 | 2015 | 205 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 130 | 0.120 |
Why?
|
| Dioxanes | 1 | 2015 | 11 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2020 | 467 | 0.120 |
Why?
|
| Hydrocortisone | 1 | 2015 | 89 | 0.110 |
Why?
|
| Crystallography, X-Ray | 2 | 2013 | 285 | 0.110 |
Why?
|
| Students | 1 | 2020 | 617 | 0.110 |
Why?
|
| Liver | 1 | 2017 | 503 | 0.110 |
Why?
|
| Benzeneacetamides | 1 | 2014 | 6 | 0.110 |
Why?
|
| Ketones | 1 | 2014 | 18 | 0.110 |
Why?
|
| Ceramidases | 1 | 2013 | 1 | 0.100 |
Why?
|
| Indoles | 2 | 2024 | 178 | 0.100 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 183 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 126 | 0.100 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 60 | 0.100 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 184 | 0.090 |
Why?
|
| Time Factors | 1 | 2017 | 1848 | 0.090 |
Why?
|
| Quinones | 1 | 2012 | 17 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2017 | 990 | 0.090 |
Why?
|
| Environmental Pollutants | 1 | 2013 | 198 | 0.080 |
Why?
|
| Lysophospholipids | 1 | 2009 | 19 | 0.080 |
Why?
|
| Sphingosine | 1 | 2009 | 22 | 0.080 |
Why?
|
| Hydrocarbons, Aromatic | 1 | 2009 | 10 | 0.080 |
Why?
|
| Hormones | 1 | 2009 | 56 | 0.080 |
Why?
|
| Microsomes, Liver | 2 | 2008 | 71 | 0.070 |
Why?
|
| Imidazoles | 1 | 2008 | 138 | 0.070 |
Why?
|
| Cell Line | 1 | 2010 | 1416 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2024 | 34 | 0.060 |
Why?
|
| Acetylation | 1 | 2024 | 108 | 0.060 |
Why?
|
| Carbazoles | 1 | 2004 | 46 | 0.050 |
Why?
|
| Histone Deacetylases | 1 | 2024 | 61 | 0.050 |
Why?
|
| Lysine | 1 | 2024 | 120 | 0.050 |
Why?
|
| Computer Simulation | 3 | 2012 | 404 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2013 | 2111 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2024 | 184 | 0.050 |
Why?
|
| Neoplasms | 1 | 2013 | 1341 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2016 | 560 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 50 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2020 | 158 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 106 | 0.040 |
Why?
|
| Cytochrome P-450 CYP3A | 2 | 2010 | 20 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2013 | 420 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 506 | 0.040 |
Why?
|
| Income | 1 | 2020 | 160 | 0.040 |
Why?
|
| Educational Status | 1 | 2020 | 335 | 0.040 |
Why?
|
| Lactones | 1 | 1998 | 22 | 0.040 |
Why?
|
| Mycobacterium | 1 | 1998 | 16 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 1998 | 33 | 0.040 |
Why?
|
| Sesquiterpenes | 1 | 1998 | 38 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 239 | 0.040 |
Why?
|
| Virus Replication | 1 | 2020 | 318 | 0.040 |
Why?
|
| Cell Growth Processes | 1 | 2018 | 43 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 145 | 0.030 |
Why?
|
| Rats | 3 | 2012 | 3701 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 683 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 159 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1574 | 0.030 |
Why?
|
| Steroid 21-Hydroxylase | 1 | 2015 | 2 | 0.030 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 2015 | 3 | 0.030 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2015 | 10 | 0.030 |
Why?
|
| Patents as Topic | 1 | 2015 | 14 | 0.030 |
Why?
|
| Polycyclic Compounds | 1 | 2015 | 7 | 0.030 |
Why?
|
| Lepidoptera | 1 | 2015 | 10 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 458 | 0.030 |
Why?
|
| Isomerism | 1 | 2014 | 65 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2014 | 157 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2013 | 27 | 0.020 |
Why?
|
| Rabbits | 1 | 2013 | 292 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2012 | 143 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 711 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 226 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2013 | 461 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4936 | 0.020 |
Why?
|
| United States | 1 | 2020 | 5072 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2009 | 103 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 5950 | 0.020 |
Why?
|
| Stilbenes | 1 | 2009 | 44 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 300 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 462 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1112 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 11819 | 0.010 |
Why?
|
| Chlorodiphenyl (54% Chlorine) | 1 | 2004 | 1 | 0.010 |
Why?
|
| Male | 2 | 2020 | 22779 | 0.010 |
Why?
|
| Tryptophan | 1 | 2004 | 66 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 13458 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 1737 | 0.010 |
Why?
|
| Mycobacterium avium | 1 | 1998 | 4 | 0.010 |
Why?
|
| Asteraceae | 1 | 1998 | 4 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1998 | 232 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1998 | 106 | 0.010 |
Why?
|